CCL19 and colorectal carcinoma: We strategically inserted the CCL19 orthologous genes in humans and mice, at the 3′ end of the PB1 gene of PR8, and successfully rescued a new oncolytic influenza virus carrying CCL19 that inhibited the CRC growth through remodeling TME, which was named as rPR8-CCL19, by reverse genetic manipulation.